Phase 1 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 65 years of age
- For people with schizophrenia: those who have been on a stable medication routine for at least two weeks before the study visit
- For people with schizophrenia: those with a diagnosed schizophrenia, schizophreniform disorder, or schizoaffective disorder
- For people with schizophrenia: those who are able to complete a PET-MR brain scan without needing sedation
Who may not be able to join:
- People who have used substances (such as drugs or alcohol) in the three months before testing
- People with an IQ below 70
- People with a serious neurological illness or significant head injury
- People who are pregnant or breastfeeding
- People who cannot safely have an MRI scan — for example, those with metal implants, pacemakers, cochlear implants, or bullets near a vital organ
- People who weigh more than 350 lbs, or whose body size cannot be accommodated by the MRI scanner
- People who have had, or currently experience, claustrophobia (fear of enclosed spaces)
- People who are unable to follow basic study requirements, such as following instructions and arriving on time
- For healthy volunteers (people without schizophrenia): those who have a parent, sibling, or child with a psychotic disorder
- For healthy volunteers: those with a lifetime diagnosis of a major psychiatric illness
- For people with schizophrenia: those experiencing unstable psychiatric symptoms at the time of testing, such as active thoughts of suicide, severe psychosis, or difficulty controlling behaviour
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jong H Yoon, MD, Stanford University
Phone: 650-849-0552
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cross-sectional differences in synaptic density between HC and SZ participants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.